ICP
PFE icon

Interchange Capital Partners’s Pfizer PFE Stock Holding History

Interchange Capital Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,600
Closed -$8.28K – 466
2026
Q1 		$8.28K Buy
+3,600
New +$95.8K ﹤0.01% 284
2025
Q2 		– Sell
-3,600
Closed -$8.28K – 306
2025
Q1 		$8.28K Buy
+3,600
New +$94.2K ﹤0.01% 274

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Interchange Capital Partners's PFE Position: Q2 2026 in Review

Interchange Capital Partners increased its Pfizer (PFE) stake by 3.5% in Q2 2026, buying an estimated $12.1K and bringing the position to 13,459 shares worth $324K. The position accounts for 0.06% of the portfolio, ranked #282.

Interchange Capital Partners first reported a position in PFE in Q4 2020 and has held it in 20 quarters since. The position peaked at $648K in Q4 2020. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Interchange Capital Partners held 13,459 shares of Pfizer worth $324K as of Q2 2026.
  • Interchange Capital Partners bought 461 Pfizer shares in Q2 2026, an estimated $12.1K.
  • Pfizer made up 0.06% of Interchange Capital Partners's portfolio in Q2 2026, its #282 holding.
  • Interchange Capital Partners first reported a position in Pfizer in Q4 2020 and has held it in 20 quarters since.
  • Interchange Capital Partners's Pfizer position peaked at $648K in Q4 2020.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Interchange Capital Partners's 13F filing for Q2 2026, filed 20 Jul 2026.